Blue Bird Corp 8-K

What Happened
Blue Bird Corporation announced on March 11, 2026 that shareholders approved an Amended and Restated 2015 Omnibus Equity Incentive Plan (effective November 21, 2025) and elected two Class III directors at the company’s annual meeting. The Incentive Plan increases the shares available for awards and extends the plan term; director elections, say-on-pay, an officer exculpation amendment, and auditor ratification were also voted on. The record date was January 15, 2026 and 28,252,219 shares (89.35% of outstanding) were represented.

Key Details

• Equity plan changes approved:
  • Total shares reserved increased from 5,200,000 to 6,100,000 (increase of 900,000 shares).
  • Full Value Awards capacity increased from 2,500,000 to 3,400,000 (increase of 900,000 shares).
  • Plan term extended from December 10, 2029 to November 21, 2035.
• Recent RSU grants under the plan (fiscal year ended Sept 27, 2025): 34,310 RSUs to non‑employee directors; 169,256 RSUs to management; CEO John Wyskiel received 102,535 RSUs per his employment agreement.
• Director election results (Class III, three‑year terms): Douglas Grimm — 21,882,659 votes for (3,994,619 withheld); Dan Thau — 24,588,619 votes for (1,288,659 withheld).
• Other shareholder votes: Proposal Two (equity plan) — 23,577,783 for / 2,272,166 against; Proposal Three (officer exculpation amendment) — 22,143,637 for / 3,546,210 against; Proposal Four (say‑on‑pay) — 24,612,253 for / 885,233 against; Proposal Five (say‑on‑frequency) — “One Year” selected (24,919,464 votes); Proposal Six (auditor ratification) — 27,855,303 for.

Why It Matters
Approval of the amended Incentive Plan gives Blue Bird more shares and flexibility to grant stock‑based compensation (including full value awards and RSUs) through 2035, which can affect dilution and executive/employee incentives. The re‑election of directors and the strong say‑on‑pay and auditor ratification votes provide governance continuity. Investors should note the size of the share increases (900,000 new shares available) and recent executive RSU grants when evaluating potential dilution and executive alignment.